Apolipoprotein E-ε4 frequency in deficit schizophrenia

European Psychiatry

Volumn 14, Issue 3, 1999, Pages 148-151

  Thibaut, F ^a   Van der Elst, A ^a   Campion, D ^a   Martin, C ^a   Coron, B ^b   Dollfus, S ^b   Frebourg, T H ^a   Petit, M ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b University of Medicine and Pharmacy Rouen   (France)

Author keywords

Apolipoprotein E; Deficit syndrome; Schizophrenia

Indexed keywords

APOLIPOPROTEIN E4; APOLIPOPROTEIN E;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; NEUROPSYCHIATRY; PHENOTYPE; PRIORITY JOURNAL; SCHIZOPHRENIA; GENETICS; METABOLISM; MIDDLE AGED;

ADULT; ALLELES; APOLIPOPROTEINS E; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA;

EID: 0033137276     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(99)80733-0     Document Type: Article

References (24)

1. Amador XF, Kirkpatrick B, Carpenter WT, Yale SA, Marcinko L. The long term stability of the deficit syndrome. Schizophr Res 1996; 18:116.
2. American Psychiatry Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edition. Washington, DC: American Psychiatric Press; 1987.
3. Andreasen NC, Olsen SA, Dennert JW. Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms. Am J Psychiatry 1982; 139:297-302.
4. 4 allele. J Neurosci 1997; 17:516-29.
5. Bickeböller H, Campion D, Brice A, Amouyel P, Hannequin D, Didierjean O, et al. Apolipoprotein E and Alzheimer disease: genotype specific risks by age and sex. Am J Hum Genet 1996; 60:439-46.
6. Carpenter WT, Buchanan RW, Kirkpatrick B, Tamminga C, Wood F Strong inference, theory testing, and the neuroanatomy of schizophrenia. Arch Gen Psychiatry 1993; 50: 825-31.
7. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261:921-23.
8. Hixson JE, Vernier DT Restriction isotyping of human ApoE by gene amplification and cleavage with Hhal. Lipid Res 1990; 31:545-8.
9. Jönsson E, Lannfelt L, Engvall B, Sedvall G. Lack of association between schizophrenia and the apolipoprotein E epsilon 4 allele. Eur Arch Psychiatry Clin Neurosci 1996; 246:182-4.
10. Joober R, Rouleau G, Fon E, Lal S, Palmour R, Bloom D, et al. Apolipoprotein E genotype in schizophrenia. Am J Med Genet 1996; 67:235.
11. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261-76.
12. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT. The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res 1989; 30:119-23.
13. Lan TH, Hong CJ, Chen JY, Sim CB. Apolipoprotein E-epsilon 4 frequency in patients with schizophrenia. Biol Psychiatry 1997; 42:225-7.
14. Marneros A, Deister A, Rhode A. Validity of the negative/positive dichotomy for schizophrenic disorders under long-term conditions. Schizophr Res 1992; 7:117-23.
15. 3 on neuronal growth in vitro. Science 1997; 264:850-2.
16. Overall JE, Gorham DE. The brief psychiatric rating scale. Psychol Rep 1961; 10:799-812.
17. Pearlson GD, Garbacz DJ, Breakey WR, Ahn HS, Depaulo JR. Lateral ventricular enlargement associated with persistent unemployment and negative symptoms in both schizophrenia and bipolar disorder. Psychiatry Res 1984; 12:1-9.
18. Pickar D, Malhotra AK, Rooney W, Breier A, Goldman D. Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia. Lancet 1997; 350:930-1.
19. 4 in schizophrenia: a study of one hundred sixteen cases with concomitant neuropathological examination. Biol Psychiatry 1997; 42:296-8.
20. Ribeyre JM, Dollfus S, Lesieur P, Ménard JF, Petit M. Instrument d'évaluation du syndrome déficitaire de la schizophrénie. Encephale 1994; 20:413-9.
21. Soininen HS, Riekkinen PJ. Apolipoprotein E, memory and Alzheimer's disease. Trends Neurosci 1996; 19:224-8.
22. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, et al. Apolipoprotein E: high avidity binding to B amyloid and increased frequency of type 4 allele in late onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90:1977-81.
23. Thibaut F, Ribeyre JM, Dourmap N, Ménard JF, Dollfus S, Petit M. Plasma 3-methoxy-4-hydroxyphenylglycol and homovanillic acid measurements in deficit and non-deficit forms of schizophrenia. Biol Psychiatry 1998; 43:24-30.
24. Zhu S, Nothen MM, Uhlhaas S, Rietschel M, Koerner J, Lanczik M, et al. Apolipoprotein E genotype distribution in schizophrenia. Psychiatr Genet 1996; 6:75-9.